Malignancy VTE Prophlyaxis

Question 1

True or False: All outpatients with cancer should be offered routine pharmacologic thromboprophylaxis

Answer 1

False

Question 2

True or False: Patients with a multiple myeloma receiving lenalidomide or thalidomide - based regimens with chemo +/or dexamethasone are contraindicated for pharmacologic thromboprophylaxis.

Answer 2

False

Question 3

What can a high risk cancer patient (with a Khorona score >2) be treated with for thromboprophylaxis?

Answer 3

Apixaban, rivaroxban, or LMWH

Question 4

High risk patients with a Khorona score of ________ may be offered thromboprophylaxis with apixaban, rivaroxaban or LMWH

Answer 4

> or equal to 2

Question 5

True or False: Recommendations for patients with malignancy apply to both outpatients and inpatients

Answer 5

False - applies to outpatients only